Zoetis UK Ltd today announced further guidance for veterinary surgeons and breeders to manage the 2024 breeding season given the current absence of Equip Artervac.

Equip Artervac is a part of the Zoetis Equip range of vaccines. It is indicated for the active immunisation for horses against equine viral arteritis (EVA) to reduce the clinical signs and shedding of the virus in nasal secretions following infection.

Following consultation with the Equine Infectious Disease Surveillance team at Cambridge University and stakeholders across the breeding industry we refer you to https://equinesurveillance.org/landing/resources/eids2024EBSActionWithoutArtervac.pdf for further information and the suggested protocol for navigating the 2024 breeding season.

Zoetis is working hard to resolve Equip Artervac supply situation and sincerely apologises for any inconvenience that may be caused and confirms its commitment to providing further information as soon as possible.

For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.


​